• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于神经退行性疾病的基于干细胞的模型和疗法。

Stem cell-based models and therapies for neurodegenerative diseases.

作者信息

Iyer Shilpa, Alsayegh Khaled, Abraham Sheena, Rao Raj R

机构信息

Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.

出版信息

Crit Rev Biomed Eng. 2009;37(4-5):321-53. doi: 10.1615/critrevbiomedeng.v37.i4-5.20.

DOI:10.1615/critrevbiomedeng.v37.i4-5.20
PMID:20528730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5653311/
Abstract

Multiple neurodegenerative disorders typically result from irrevocable damage and improper functioning of specialized neuronal cells or populations of neuronal cells. These disorders have the potential to contribute to an already overburdened health care system unless the progression of neurodegeneration can be altered. Progress in understanding neurodegenerative cell biology has been hampered by a lack of predictive and, some would claim, relevant cellular models. Additionally, the research needed to develop new drugs and determine methods for repair or replacement of damaged neurons is severely hampered by the lack of an adequate in vitro human neuron cell-based model. In this context, pluripotent stem cells and neural progenitors and their properties including unlimited proliferation, plasticity to generate other cell types, and a readily available source of cells--pose an excellent alternative to ex vivo primary cultures or established immortalized cell lines in contributing to our understanding of neurodegenerative cell biology and our ability to analyze the therapeutic or cytotoxic effects of chemicals, drugs, and xenobiotics. Many questions that define the underlying "genesis" of the neuronal death in these disorders also remain unanswered, with evidence suggesting a key role for mitochondrial dysfunction. The assessment of stem cells, neural progenitors, and engineered adult cells can provide useful insights into neuronal development and neurodegenerative processes. Finally, the potential for a combination of cell- and gene-based therapeutics for neurodegenerative disorders is also discussed.

摘要

多种神经退行性疾病通常源于特殊神经元细胞或神经元细胞群体的不可逆转损伤和功能异常。除非神经退行性变的进程能够改变,否则这些疾病有可能给本已不堪重负的医疗保健系统带来压力。由于缺乏可预测且有人认为相关的细胞模型,对神经退行性细胞生物学的理解进展受到阻碍。此外,由于缺乏适当的基于人源神经元细胞的体外模型,开发新药以及确定修复或替换受损神经元方法所需的研究也受到严重阻碍。在这种情况下,多能干细胞和神经祖细胞及其特性,包括无限增殖、生成其他细胞类型的可塑性以及易于获取的细胞来源,在帮助我们理解神经退行性细胞生物学以及分析化学物质、药物和外源性物质的治疗或细胞毒性作用方面,是体外原代培养或已建立的永生化细胞系的极佳替代选择。许多界定这些疾病中神经元死亡潜在“成因”的问题仍然没有答案,有证据表明线粒体功能障碍起关键作用。对干细胞、神经祖细胞和工程化成年细胞的评估可为神经元发育和神经退行性过程提供有用的见解。最后,还讨论了基于细胞和基因的联合疗法治疗神经退行性疾病的潜力。

相似文献

1
Stem cell-based models and therapies for neurodegenerative diseases.用于神经退行性疾病的基于干细胞的模型和疗法。
Crit Rev Biomed Eng. 2009;37(4-5):321-53. doi: 10.1615/critrevbiomedeng.v37.i4-5.20.
2
Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.利用多能干细胞技术对人类神经退行性疾病进行逆向工程研究。
Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.
3
Neurodegeneration and cell replacement.神经退行性变与细胞替代
Philos Trans R Soc Lond B Biol Sci. 2008 Jan 12;363(1489):153-70. doi: 10.1098/rstb.2006.2018.
4
Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.人类多能干细胞在神经退行性疾病中的应用:潜力、进展与局限。
Curr Stem Cell Res Ther. 2020;15(2):102-110. doi: 10.2174/1574888X14666190823142911.
5
Stem cell transplantation for neurometabolic and neurodegenerative diseases.干细胞移植治疗神经代谢和神经退行性疾病。
Neuropharmacology. 2010 May;58(6):845-54. doi: 10.1016/j.neuropharm.2009.12.015. Epub 2009 Dec 28.
6
Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.用于神经退行性疾病自体细胞替代疗法的成人人类神经干细胞。
NeuroRehabilitation. 2006;21(3):255-65.
7
Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy.神经退行性疾病的人诱导多能干细胞模型用于研究自噬的生物医学意义。
J Mol Biol. 2020 Apr 3;432(8):2754-2798. doi: 10.1016/j.jmb.2020.01.024. Epub 2020 Feb 7.
8
Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain.与脑退行性疾病的干细胞研究和干预相关的科学和伦理问题。
Prog Neurobiol. 2013 Nov;110:63-73. doi: 10.1016/j.pneurobio.2013.04.003. Epub 2013 May 7.
9
The stem cells as a potential treatment for neurodegeneration.干细胞作为神经退行性疾病的一种潜在治疗方法。
Methods Mol Biol. 2007;399:199-213. doi: 10.1007/978-1-59745-504-6_14.
10
The promise of stem cells for neural repair.干细胞用于神经修复的前景。
Brain Res. 2006 May 26;1091(1):258-64. doi: 10.1016/j.brainres.2006.01.073. Epub 2006 Mar 23.

引用本文的文献

1
The Therapeutic Potential of Stem Cells in Depression.干细胞在抑郁症中的治疗潜力
Int J Mol Sci. 2025 Aug 27;26(17):8306. doi: 10.3390/ijms26178306.
2
Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.由携带线粒体突变的患者衍生的诱导多能干细胞表现出改变的生物能量学和异常的分化潜能。
Stem Cell Res Ther. 2023 Nov 7;14(1):320. doi: 10.1186/s13287-023-03546-7.
3
Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome.用于莱氏综合征的人诱导多能干细胞中线粒体形态的定量分析。
Stem Cell Res. 2021 Dec;57:102572. doi: 10.1016/j.scr.2021.102572. Epub 2021 Oct 12.
4
Leigh Syndrome: A Tale of Two Genomes.Leigh综合征:两个基因组的故事
Front Physiol. 2021 Aug 11;12:693734. doi: 10.3389/fphys.2021.693734. eCollection 2021.
5
Quantifying Mitochondrial Dynamics in Patient Fibroblasts with Multiple Developmental Defects and Mitochondrial Disorders.量化具有多种发育缺陷和线粒体疾病的患者成纤维细胞中的线粒体动态。
Int J Mol Sci. 2021 Jun 10;22(12):6263. doi: 10.3390/ijms22126263.
6
mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.T8993G Leigh 综合征成纤维细胞的 mRNA 重编程,用于创建线粒体疾病的诱导多能干细胞模型。
Stem Cells Dev. 2019 Jul 1;28(13):846-859. doi: 10.1089/scd.2019.0045. Epub 2019 May 20.
7
Stem cells, neural progenitors, and engineered stem cells.干细胞、神经祖细胞和工程干细胞。
Methods Mol Biol. 2015;1254:255-67. doi: 10.1007/978-1-4939-2152-2_19.
8
Novel therapeutic approaches for Leber's hereditary optic neuropathy.治疗Leber遗传性视神经病变的新型疗法。
Discov Med. 2013 Mar;15(82):141-9.
9
Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells.线粒体基因治疗改善 G11778A 莱伯遗传性视神经病变和 T8993G Leigh 综合征细胞的呼吸、生物发生和转录。
Hum Gene Ther. 2012 Jun;23(6):647-57. doi: 10.1089/hum.2011.177. Epub 2012 Apr 17.
10
Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors.人多能干细胞源性神经祖细胞中线粒体基因替换。
Gene Ther. 2012 May;19(5):469-75. doi: 10.1038/gt.2011.134. Epub 2011 Sep 15.

本文引用的文献

1
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.磷质子磁共振波谱显示早、晚期帕金森病中线粒体功能障碍。
Brain. 2009 Dec;132(Pt 12):3285-97. doi: 10.1093/brain/awp293.
2
Molecular pathogenesis of Parkinson disease: insights from genetic studies.帕金森病的分子发病机制:来自遗传学研究的见解
Expert Rev Mol Med. 2009 Jul 27;11:e22. doi: 10.1017/S1462399409001148.
3
Role of bioinspired polymers in determination of pluripotent stem cell fate.仿生聚合物在多能干细胞命运决定中的作用。
Regen Med. 2009 Jul;4(4):561-78. doi: 10.2217/rme.09.23.
4
Mitochondria: determinants of stem cell fate?线粒体:干细胞命运的决定因素?
Stem Cells Dev. 2009 Jul-Aug;18(6):803-6. doi: 10.1089/scd.2009.1806.edi.
5
Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation.含有致病性线粒体DNA(mtDNA)突变的转线粒体胚胎干细胞在神经元分化方面存在缺陷。
Cell Prolif. 2009 Aug;42(4):413-24. doi: 10.1111/j.1365-2184.2009.00612.x. Epub 2009 Jun 23.
6
Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression.具有 N 端线粒体转导结构域的重组线粒体转录因子 A 可增加呼吸作用和线粒体基因表达。
Mitochondrion. 2009 Jun;9(3):196-203. doi: 10.1016/j.mito.2009.01.012. Epub 2009 Feb 4.
7
Adult neural stem cells in the mammalian central nervous system.哺乳动物中枢神经系统中的成年神经干细胞。
Cell Res. 2009 Jun;19(6):672-82. doi: 10.1038/cr.2009.56.
8
Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.线粒体基因疗法可增强帕金森病细胞模型中的线粒体生理功能。
Hum Gene Ther. 2009 Aug;20(8):897-907. doi: 10.1089/hum.2009.023.
9
The cybrid model of sporadic Parkinson's disease.散发性帕金森病的细胞杂交模型。
Exp Neurol. 2009 Aug;218(2):320-5. doi: 10.1016/j.expneurol.2009.03.016. Epub 2009 Mar 26.
10
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.不含病毒重编程因子的帕金森病患者来源诱导多能干细胞
Cell. 2009 Mar 6;136(5):964-77. doi: 10.1016/j.cell.2009.02.013.